BioGaia AB (publ) (ST:BIOG-B) — Stock Price

Skr112.50 SEK
▲ 0.90% today

BioGaia AB (publ) (ST:BIOG-B) is currently trading at Skr112.50 SEK, up 0.90% today. Over the past 52 weeks, shares have ranged between Skr93.65 and Skr134.90. This page tracks BioGaia AB (publ)'s live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see BIOG-B company net worth.

BioGaia AB (publ) (BIOG-B) Stock Price Chart — Daily History & Trading Volume

The chart below tracks BioGaia AB (publ)'s daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.

BioGaia AB (publ) Income Statement — Revenue, Profit & Earnings by Year

BioGaia AB (publ)'s annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Skr1.54 Billion Skr1.42 Billion Skr1.30 Billion Skr1.10 Billion Skr785.11 Million
Cost of Revenue Skr409.59 Million Skr391.98 Million Skr346.32 Million Skr302.03 Million Skr202.16 Million
Gross Profit Skr1.13 Billion Skr1.03 Billion Skr950.19 Million Skr801.93 Million Skr582.95 Million
Research & Development Skr115.72 Million Skr157.10 Million Skr106.78 Million Skr106.81 Million Skr105.47 Million
SG&A Skr47.65 Million Skr41.62 Million Skr39.25 Million Skr39.82 Million Skr42.55 Million
Total Operating Expenses Skr716.11 Million Skr607.37 Million Skr507.09 Million Skr467.26 Million Skr340.35 Million
Operating Income Skr412.47 Million Skr423.37 Million Skr443.10 Million Skr361.46 Million Skr253.74 Million
EBITDA Skr454.33 Million Skr539.44 Million Skr494.92 Million Skr476.89 Million Skr276.86 Million
EBIT Skr429.67 Million Skr462.74 Million Skr469.64 Million Skr453.00 Million Skr253.84 Million
Interest Expense Skr8.45 Million Skr14.92 Million Skr809.00K Skr5.39 Million Skr1.13 Million
Income Before Tax Skr421.22 Million Skr447.82 Million Skr468.83 Million Skr447.61 Million Skr252.71 Million
Income Tax Expense Skr88.45 Million Skr96.43 Million Skr103.48 Million Skr73.84 Million Skr56.44 Million
Net Income Skr332.76 Million Skr351.39 Million Skr365.35 Million Skr373.77 Million Skr196.27 Million

BioGaia AB (publ) Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes BioGaia AB (publ)'s financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Skr1.60 Billion Skr2.03 Billion Skr2.33 Billion Skr2.21 Billion Skr2.13 Billion
Total Current Assets Skr1.22 Billion Skr1.61 Billion Skr1.87 Billion Skr1.80 Billion Skr1.75 Billion
Cash & Equivalents Skr801.31 Million Skr1.22 Billion Skr1.54 Billion Skr1.49 Billion Skr1.48 Billion
Short-term Investments — — — — —
Net Receivables Skr236.49 Million Skr222.47 Million Skr112.62 Million Skr130.70 Million Skr-102.74 Million
Inventory Skr166.70 Million Skr152.89 Million Skr181.20 Million Skr142.84 Million Skr102.74 Million
Property, Plant & Equipment Skr181.15 Million Skr205.62 Million Skr213.33 Million Skr157.72 Million Skr153.63 Million
Goodwill Skr146.50 Million Skr175.10 Million Skr165.17 Million Skr171.52 Million Skr149.23 Million
Total Liabilities Skr283.59 Million Skr310.07 Million Skr302.85 Million Skr241.55 Million Skr250.69 Million
Total Current Liabilities Skr199.14 Million Skr206.20 Million Skr195.74 Million Skr164.99 Million Skr126.95 Million
Long-term Debt — — — — —
Net Debt Skr-794.41 Million Skr-1.22 Billion Skr-1.54 Billion Skr-1.47 Billion Skr-1.47 Billion
Total Stockholder Equity Skr1.31 Billion Skr1.72 Billion Skr2.03 Billion Skr1.97 Billion Skr1.88 Billion
Retained Earnings Skr123.16 Million Skr491.04 Million Skr840.83 Million Skr772.73 Million Skr703.19 Million

BioGaia AB (publ) Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how BioGaia AB (publ) generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Skr306.57 Million Skr373.22 Million Skr425.96 Million Skr318.94 Million Skr221.88 Million
Capital Expenditures Skr3.60 Million Skr14.15 Million Skr48.71 Million Skr17.92 Million Skr6.38 Million
Free Cash Flow Skr302.97 Million Skr359.06 Million Skr377.25 Million Skr301.03 Million Skr215.50 Million
Investing Cash Flow Skr-3.34 Million Skr-14.07 Million Skr-50.94 Million Skr-18.14 Million Skr-126.97 Million
Financing Cash Flow Skr-709.87 Million Skr-689.72 Million Skr-308.42 Million Skr-313.59 Million Skr-81.85 Million
Dividends Paid Skr-698.02 Million Skr-696.78 Million Skr-292.85 Million Skr301.33 Million Skr68.87 Million
Stock-Based Compensation — — — — —
Depreciation Skr24.67 Million Skr25.55 Million Skr25.28 Million Skr23.89 Million Skr27.24 Million
Change in Cash Skr-422.67 Million Skr-320.21 Million Skr55.83 Million Skr3.69 Million Skr16.80 Million

BioGaia AB (publ) Earnings History — EPS Actual vs. Analyst Estimates

Track BioGaia AB (publ)'s quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 07, 2026 0.78 0.70 +11.43%
Feb 12, 2026 0.98 0.80 +22.50%
Oct 22, 2025 0.65 0.70 -7.14%
Jul 18, 2025 0.87 1.00 -13.00%
May 05, 2025 0.79 — —
Feb 12, 2025 0.81 0.59 +37.29%
Oct 22, 2024 0.36 0.64 -43.75%
Jul 23, 2024 1.10 0.95 +15.79%